Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page
- Check4 days agoChange DetectedFooter now includes 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' references were removed.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA minor version update was applied: Revision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page revision is updated to v3.3.1, replacing the previous v3.2.0.SummaryDifference0.1%

- Check40 days agoChange DetectedRemoved a government funding/operating status notice from the page; the core trial information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check54 days agoChange DetectedThe new screenshot shows a layout change (header/navigation/spacing) with no changes to the actual study details or criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference6%

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.